Real world data (RWD) reduces study costs, accelerates timelines and shortens time to market
- RWD and RWE bring increasing value to pharmaceutical and medical technology (MedTech) companies to accelerate study timelines, shorten time to market, demonstrate safety and efficacy, and even maximize commercial success
- In a published report based on a 2020 industry survey, more than 80% of responding companies indicated they are entering into strategic partnerships to access new sources of RWD
- There is a marked increase in the prevalence and value that RWE/RWD will continue to provide to pharmaceutical and MedTech companies throughout a products lifecycle
Click here to learn more.
SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.